ATS 2018 International Conference - Mobile

Oropharyngeal Bleomycin Upregulates Drug Efflux Transporters and Reduces Lung Exposure to Substrate Compounds: A Pitfall for Pharmacological Studies on Pulmonary Fibrosis [Board No. P652]

Location: Board no. P652

Session Type: Thematic Poster Session

Sunday

May

20

11:15 AM

1:00 PM

Speaker(s)/Author(s)

George Kunos

MD, PhD
National Institute on Alcohol Abuse and Alcoholism

May Christine V. Malicdan

MD, PhD
National Human Genome Research Institute

Joshua Park

Bachelor of Science
National Institute on Alcohol Abuse and Alcoholism

Steven Bodine

Bachelor of Science
National Human Genome Research Institute

Nathan J. Coffey

Bachelor of Science
National Institute on Alcohol Abuse and Alcoholism

Resat Cinar

BScPh, PhD, MBA
National Institute on Alcohol Abuse and Alcoholism

Bernadette R. Gochuico

MD
National Human Genome Research Institute;National Human Genome Research Institute, NIH;Natl Inst of Hlth

William A. Gahl

MD, PhD
National Human Genome Research Institute;National Human Genome Research Institute, NIH, Medical Genetics Branch, NHGRI

View Abstract

Oropharyngeal Bleomycin Upregulates Drug Efflux Transporters and Reduces Lung Exposure to Substrate Compounds: A Pitfall for Pharmacological Studies on Pulmonary Fibrosis

Parent Sessions

A68 - MOLECULAR DETERMINANTS OF REMODELING IN LUNG FIBROSIS...
05-20-2018 9:15 AM - 4:15 PM